Suppr超能文献

正常或轻度降低的肾功能、心血管风险与动脉粥样硬化生物标志物之间的关联:ENCORE试验结果

Association between normal or mildly reduced kidney function, cardiovascular risk and biomarkers for atherosclerosis: results from the ENCORE trial.

作者信息

Tyson Crystal C, Smith Patrick J, Sherwood Andrew, Mabe Stephanie, Hinderliter Alan L, Blumenthal James A

机构信息

Department of Medicine, Duke University Medical Center, Durham, NC, USA.

Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA.

出版信息

Clin Kidney J. 2017 Oct;10(5):666-671. doi: 10.1093/ckj/sfx025. Epub 2017 May 2.

Abstract

BACKGROUND

Moderate-to-severe kidney dysfunction is associated with atherosclerotic cardiovascular disease (ASCVD). Gradations of normal or mildly reduced kidney function may also associate with ASCVD risk.

METHODS

We conducted a secondary analysis using baseline data from the Exercise and Nutritional Interventions for Cardiovascular Health (ENCORE) trial. Participants were sedentary, overweight and obese adults with unmedicated pre-hypertension or Stage I hypertension and an estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m. The Pooled Cohorts Equations were used to estimate a 10-year risk for first ASCVD event. Carotid artery intima-media thickness (IMT) and brachial artery flow-mediated dilation (FMD) were measured to assess subclinical atherosclerosis and vascular endothelial function, respectively. Using linear regression, we examined the association between eGFR and ASCVD risk, IMT and FMD.

RESULTS

Participants ( = 139) were predominantly women (65%), white (60%), with a mean age of 52.0 ± 9.6 years and mean eGFR of 89.1 ± 15.0 mL/min/1.73 m. Lower eGFR of 15 mL/min/1.73 m was associated with higher ASCVD risk [ = -2.7% (95% confidence interval: -3.7, -1.8%), P < 0.001], higher IMT [ = 0.05 mm (0.03, 0.08 mm), P < 0.001] and lower FMD [ = -0.87% (-1.64, -0.11%), P = 0.026]. Compared with eGFR ≥90 mL/min/1.73 m, those with eGFR 60-89 mL/min/1.73 m had higher mean ASCVD risk (7.6% versus 2.7%; P < 0.001), greater mean IMT (0.74 mm versus 0.66 mm; P < 0.001) and lower mean FMD (2.0% versus 3.7%; P = 0.026). After controlling for CVD risk factors, the association between eGFR and IMT remained significant (P < 0.001), and eGFR and FMD trended toward significance (P = 0.08).

CONCLUSIONS

Among overweight and obese adults with unmedicated high blood pressure and eGFR ≥60 mL/min/1.73 m, lower eGFR is associated with a greater 10-year risk for first ASCVD event, higher IMT and relatively impaired FMD.

摘要

背景

中重度肾功能不全与动脉粥样硬化性心血管疾病(ASCVD)相关。正常或轻度降低的肾功能分级也可能与ASCVD风险相关。

方法

我们使用心血管健康运动与营养干预(ENCORE)试验的基线数据进行了二次分析。参与者为久坐不动、超重和肥胖的成年人,患有未经药物治疗的高血压前期或I期高血压,估计肾小球滤过率(eGFR)≥60 mL/(min·1.73 m²)。使用合并队列方程估计首次发生ASCVD事件的10年风险。测量颈动脉内膜中层厚度(IMT)和肱动脉血流介导的舒张功能(FMD),分别评估亚临床动脉粥样硬化和血管内皮功能。我们使用线性回归分析了eGFR与ASCVD风险、IMT和FMD之间的关联。

结果

参与者(n = 139)主要为女性(65%),白人(60%),平均年龄52.0±9.6岁,平均eGFR为89.1±15.0 mL/(min·1.73 m²)。eGFR每降低15 mL/(min·1.73 m²)与更高的ASCVD风险相关[β = -2.7%(95%置信区间:-3.7,-1.8%),P < 0.001]、更高的IMT[β = 0.05 mm(0.03,0.08 mm),P < 0.001]和更低的FMD[β = -0.87%(-1.64,-0.11%),P = 0.026]。与eGFR≥90 mL/(min·1.73 m²)的参与者相比,eGFR为60 - 89 mL/(min·1.73 m²)的参与者平均ASCVD风险更高(7.6%对2.7%;P < 0.001)、平均IMT更大(0.74 mm对0.66 mm;P < 0.001)且平均FMD更低(2.0%对3.7%;P = 0.026)。在控制心血管疾病风险因素后,eGFR与IMT之间的关联仍然显著(P < 0.001),eGFR与FMD之间的关联有显著趋势(P = 0.08)。

结论

在患有未经药物治疗的高血压且eGFR≥60 mL/(min·1.73 m²)的超重和肥胖成年人中,较低的eGFR与首次发生ASCVD事件的10年风险更高、IMT更高以及FMD相对受损相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560b/5622906/8fd332f8d393/sfx025f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验